Impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes: an open label, randomised active-comparator trial
Phase of Trial: Phase III
Latest Information Update: 15 May 2018
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LYDIA
- 03 May 2018 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 16 Nov 2016 Planned End Date changed from 30 Jun 2016 to 1 Jul 2017.